
Consilient Health Ireland have announced that Azalia® 75mcg desogestrel has become available on the GMS Reimbursement Scheme from 1st January 2017. Azalia® will be reimbursed at €7.47 for three months’ supply. Azalia® contains the same active ingredient as Cerazette® and is a high quality cost effective equivalent which offers patients savings on their contraceptive prescription. Further information on Violite™ can be found here.